Phase III trial of Novavax's VLP trivalent seasonal influenza virus vaccine.
Phase of Trial: Phase III
Latest Information Update: 10 Sep 2009
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Novavax
- 10 Sep 2009 New trial record.